Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Taspoglutide

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy

Roche · Phase 3 · Completed · Enrollment 305

NCT00823992

ArmPopulationDoseWeeksEstimandWeight change
placeboT2D onlyn/r4n/rn/r
taspoglutideT2D onlyn/r4n/rn/r